Exact Mass: 493.1687564
Exact Mass Matches: 493.1687564
Found 76 metabolites which its exact mass value is equals to given mass value 493.1687564
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
aspoxicillin
C21H27N5O7S (493.16311120000006)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D07469
6-[[2-[[2-Amino-4-(methylamino)-4-oxobutanoyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
C21H27N5O7S (493.16311120000006)
Dasabuvir
C26H27N3O5S (493.1671332000001)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent
L-Aspoxicillin trihydrate
C21H27N5O7S (493.16311120000006)
Ala Cys Asp Trp
C21H27N5O7S (493.16311120000006)
Ala Cys Trp Asp
C21H27N5O7S (493.16311120000006)
Ala Asp Cys Trp
C21H27N5O7S (493.16311120000006)
Ala Asp Trp Cys
C21H27N5O7S (493.16311120000006)
Ala Trp Cys Asp
C21H27N5O7S (493.16311120000006)
Ala Trp Asp Cys
C21H27N5O7S (493.16311120000006)
Cys Ala Asp Trp
C21H27N5O7S (493.16311120000006)
Cys Ala Trp Asp
C21H27N5O7S (493.16311120000006)
Cys Asp Ala Trp
C21H27N5O7S (493.16311120000006)
Cys Asp Trp Ala
C21H27N5O7S (493.16311120000006)
Cys Glu Gly Trp
C21H27N5O7S (493.16311120000006)
Cys Glu Trp Gly
C21H27N5O7S (493.16311120000006)
Cys Gly Glu Trp
C21H27N5O7S (493.16311120000006)
Cys Gly Trp Glu
C21H27N5O7S (493.16311120000006)
Cys Trp Ala Asp
C21H27N5O7S (493.16311120000006)
Cys Trp Asp Ala
C21H27N5O7S (493.16311120000006)
Cys Trp Glu Gly
C21H27N5O7S (493.16311120000006)
Cys Trp Gly Glu
C21H27N5O7S (493.16311120000006)
Asp Ala Cys Trp
C21H27N5O7S (493.16311120000006)
Asp Ala Trp Cys
C21H27N5O7S (493.16311120000006)
Asp Cys Ala Trp
C21H27N5O7S (493.16311120000006)
Asp Cys Trp Ala
C21H27N5O7S (493.16311120000006)
Asp Trp Ala Cys
C21H27N5O7S (493.16311120000006)
Asp Trp Cys Ala
C21H27N5O7S (493.16311120000006)
Glu Cys Gly Trp
C21H27N5O7S (493.16311120000006)
Glu Cys Trp Gly
C21H27N5O7S (493.16311120000006)
Glu Gly Cys Trp
C21H27N5O7S (493.16311120000006)
Glu Gly Trp Cys
C21H27N5O7S (493.16311120000006)
Glu Trp Cys Gly
C21H27N5O7S (493.16311120000006)
Glu Trp Gly Cys
C21H27N5O7S (493.16311120000006)
Gly Cys Glu Trp
C21H27N5O7S (493.16311120000006)
Gly Cys Trp Glu
C21H27N5O7S (493.16311120000006)
Gly Glu Cys Trp
C21H27N5O7S (493.16311120000006)
Gly Glu Trp Cys
C21H27N5O7S (493.16311120000006)
Gly Trp Cys Glu
C21H27N5O7S (493.16311120000006)
Gly Trp Glu Cys
C21H27N5O7S (493.16311120000006)
Trp Ala Cys Asp
C21H27N5O7S (493.16311120000006)
Trp Ala Asp Cys
C21H27N5O7S (493.16311120000006)
Trp Cys Ala Asp
C21H27N5O7S (493.16311120000006)
Trp Cys Asp Ala
C21H27N5O7S (493.16311120000006)
Trp Cys Glu Gly
C21H27N5O7S (493.16311120000006)
Trp Cys Gly Glu
C21H27N5O7S (493.16311120000006)
Trp Asp Ala Cys
C21H27N5O7S (493.16311120000006)
Trp Asp Cys Ala
C21H27N5O7S (493.16311120000006)
Trp Glu Cys Gly
C21H27N5O7S (493.16311120000006)
Trp Glu Gly Cys
C21H27N5O7S (493.16311120000006)
Trp Gly Cys Glu
C21H27N5O7S (493.16311120000006)
Trp Gly Glu Cys
C21H27N5O7S (493.16311120000006)
(2R,3R)-2,3-dihydroxybutanedioic acid,5-fluoro-1-(2-fluorophenyl)-3-[[(3S)-piperidin-3-yl]methoxy]indazole
C23H25F2N3O7 (493.16604839999997)
Apatinib
C25H27N5O4S (493.1783662000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
Minocycline hydrochloride
C23H28ClN3O7 (493.16156880000005)
C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Minocycline hydrochloride is an orally active, potent and BBB-penetrated semi-synthetic tetracycline antibiotic. Minocycline hydrochloride is a hypoxia-inducible factor (HIF)-1α inhibitor. Minocycline hydrochloride shows anti-cancer, anti-inflammatory, and glutamate antagonist effects. Minocycline hydrochloride reduces glutamate neurotransmission and shows neuroprotective properties and antidepressant effects. Minocycline hydrochloride inhibits bacterial protein synthesis through binding with the 30S subunit of the bacterial ribosome, resulting in a bacteriostatic effect[1][2][3][4][5][6][7].
N-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyl)-3-fluorenylcarboxamide
NGB 2904 is a potent, selective, orally active and brain-penetrated antagonist of dopamine D3 receptor, with a Ki of 1.4 nM. NGB 2904 shows selectivity for D3 over D2, 5-HT2, α1, D4, D1 and D5 receptors (Kis=217, 223, 642, >5000, >10000 and >10000 nM, respectively). NGB 2904 antagonizes Quinpirole-stimulated mitogenesis[1][2].
Dasabuvir
C26H27N3O5S (493.1671332000001)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent
4-[3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4,6-dimethyl-9-oxoimidazo[1,2-a]purin-7-yl]-2-(methoxycarbonylamino)butanoate
C20H25N6O9- (493.16829399999995)
Minocin
C23H28ClN3O7 (493.16156880000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
[4-[2-(3-Chlorophenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-phenylmethanone
2-[5-[[2-(3-methoxypropylamino)-2-oxoethyl]thio]-3-oxo-2H-imidazo[1,2-c]quinazolin-2-yl]-N-(phenylmethyl)acetamide
C25H27N5O4S (493.1783662000001)
(11r,15s,16s)-14,15-dimethoxy-20-methyl-19-oxo-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl benzoate
C27H27NO8 (493.17365820000003)
(1r,11s,13s,14r,15s,16s)-14,15-dimethoxy-20-methyl-19-oxo-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl benzoate
C27H27NO8 (493.17365820000003)
2,3-dihydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
C27H27NO8 (493.17365820000003)
(2s,3r,4r,5s,6r)-2,3-dihydroxy-6-(3-hydroxy-4-methoxyphenyl)-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
C27H27NO8 (493.17365820000003)